Insider · CIK 0001966214
Shane Thomas Gleason
Files at NSPR (InspireMD, Inc.). First filing Feb 2, 2026, latest May 21, 2026.
In brief
Shane Thomas Gleason files SEC Form 4 as officer at NSPR (InspireMD, Inc.). Since Feb 2, 2026, Shane Thomas Gleason has reported 0 open-market buys worth $0 and 2 open-market sells worth $289k, the latest filed on May 21, 2026.
A track record needs three past buys with six months of prices behind them; Shane Thomas Gleason has 0, so none is measured yet.
The newest scored trade: sold $190k of NSPR on Jan 27, 2025, filed May 21, 2026, scored 27 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $289k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NSPR: InspireMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | NSPRsell InspireMD, Inc. | $190k 85,295 shares | -7% | +18% from low-15% from high | |
| 25Weak | NSPRsell InspireMD, Inc. | $99k 61,194 shares | -5% | +1% from low-57% from high |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -3,858 | $2.71 | $10k | 1,135,319 | May 21, 2026 |
| Jan 28, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,476 | $2.61 | $6,462 | 1,132,843 | May 21, 2026 |
| Jan 29, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -3,660 | $2.46 | $9,004 | 1,129,183 | May 21, 2026 |
| Jan 30, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,454 | $2.51 | $6,160 | 1,126,729 | May 21, 2026 |
| Jan 31, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -9,923 | $2.55 | $25k | 1,116,806 | May 21, 2026 |
| Feb 3, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -7,073 | $2.51 | $18k | 1,109,733 | May 21, 2026 |
| Feb 4, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -5,132 | $2.46 | $13k | 1,104,601 | May 21, 2026 |
| Feb 25, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -10,000 | $3.65 | $37k | 1,094,601 | May 21, 2026 |
| May 23, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,482 | $2.51 | $6,230 | 1,092,119 | May 21, 2026 |
| May 27, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -1,572 | $2.51 | $3,946 | 1,090,547 | May 21, 2026 |
| May 29, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -3,760 | $2.51 | $9,438 | 1,086,787 | May 21, 2026 |
| May 30, 2025 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -7,186 | $2.51 | $18k | 1,079,601 | May 21, 2026 |
| Feb 2, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,941 | $1.59 | $4,676 | 1,076,660 | May 21, 2026 |
| May 19, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -22,778 | $1.01 | $23k | 1,053,882 | May 21, 2026 |
| Jan 15, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,909 | $1.58 | $4,593 | 1,197,462 | Feb 2, 2026 |
| Jan 16, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,250 | $1.61 | $3,627 | 1,195,212 | Feb 2, 2026 |
| Jan 20, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,955 | $1.59 | $4,710 | 1,192,257 | Feb 2, 2026 |
| Jan 21, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -17,593 | $1.62 | $29k | 1,174,664 | Feb 2, 2026 |
| Jan 22, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -8,411 | $1.57 | $13k | 1,166,253 | Feb 2, 2026 |
| Jan 27, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -4,781 | $1.66 | $7,956 | 1,161,472 | Feb 2, 2026 |
| Jan 28, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -12,395 | $1.65 | $20k | 1,149,077 | Feb 2, 2026 |
| Jan 29, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -5,000 | $1.65 | $8,250 | 1,144,077 | Feb 2, 2026 |
| Jan 30, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,900 | $1.63 | $4,730 | 1,141,177 | Feb 2, 2026 |
| Feb 2, 2026 | NSPR InspireMD, Inc. | SOpen-market sale Common Stock | -2,000 | $1.60 | $3,208 | 1,139,177 | Feb 2, 2026 |
| Jan 14, 2026 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +453,390 | $0.00 | $0 | 1,200,371 | Jan 16, 2026 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +232,616 | $0.00 | $0 | 746,981 | Jan 10, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Options to purchase common stock (right to buy)derivative | +106,218 | $0.00 | $0 | 289,346 | Jan 10, 2025 |
Questions about Shane Thomas Gleason
Answered from the filings on this page, as of the latest one.
Is Shane Thomas Gleason buying or selling?
In the last 12 months Shane Thomas Gleason reported 0 open-market buys worth $0 and 2 open-market sells worth $289k on SEC Form 4; the latest was sold $190k of NSPR on Jan 27, 2025. Grants, option exercises and tax withholding are not counted.
How did Shane Thomas Gleason's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shane Thomas Gleason has 0.
Where does Shane Thomas Gleason file Form 4?
Shane Thomas Gleason has filed Form 4 at NSPR (InspireMD, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.